Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy

Abstract

Atezolizumab successfully reinvigorated JC virus immunity in a patient in Belgium with progressive multifocal leukoencephalopathy, as demonstrated by clinical, virologic, and radiologic response to treatment. However, the treatment also resulted in immune reconstitution inflammatory syndrome and life-threatening immune-related adverse events. These conditions were treated with corticosteroids, leading to treatment resistance.

Keywords

• progressive multifocal leukoencephalopathy
• immunotherapy
• JC virus
• immune reconstitution inflammatory syndrome
• Belgium
• viruses